The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia

Guo G.; Xu S.; Cao L. -D.; Wu Q. -Y.

首页> 外文期刊>European review for medical and pharmacological sciences. >The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia

【24h】

The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia

机译：盐酸左旋多巴苄丝肼对帕金森病患者高半胱氨酸水平的影响及高同型半胱氨酸血症的治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE: This study aims to investigate hyperhomocysteinemia (HHcy) resulted from treatment in patients with Parkinson's disease (PD) and to evaluate the therapeutic outcome of HHcy.

机译：目的：本研究旨在研究帕金森病（PD）患者治疗引起的高同型半胱氨酸血症（HHcy），并评估其治疗效果。

著录项

来源
《European review for medical and pharmacological sciences.》 |2016年第11期|共4页
作者
Guo G.; Xu S.; Cao L. -D.; Wu Q. -Y.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Parkinson's disease; Levodopa; Hyperhomocysteine; Cerebral infarction;

机译：帕金森氏病;左旋多巴;高同型半胱氨酸;脑梗塞;

相似文献

外文文献
中文文献
专利

1. The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia [J] . Guo G., Xu S., Cao L. -D., European review for medical and pharmacological sciences. . 2016,第11期

机译：盐酸左旋多巴苄丝肼对帕金森病患者高半胱氨酸水平的影响及高同型半胱氨酸血症的治疗
2. Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility-an open-label, 6-week study [J] . Karla Eggert, Orjan Skogar, Khaled Amar, Journal of neural transmission . 2010,第3期

机译：帕金森氏病伴衰老患者从左旋多巴/苄丝肼或左旋多巴/卡比多巴直接转换为左旋多巴/卡比多巴/他他酮：有效性，安全性和可行性-一项开放性的6周研究
3. Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study [J] . Karla Eggert, Örjan Skogar, Khaled Amar, Journal of Neural Transmission . 2010,第3期

机译：帕金森病伴衰老患者从左旋多巴/苄丝肼或左旋多巴/卡比多巴直接转换为左旋多巴/卡比多巴/他那卡酮：有效性，安全性和可行性—一项开放性的6周研究
4. Detection of Levodopa Induced Dyskinesia in Parkinson's Disease patients based on activity classification [C] . Jalloul Nahed, Poree Fabienne, Viardot Geoffrey, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2015

机译：基于活动分类的帕金森病患者左旋多巴诱发的运动障碍的检测
5. Objective Vision-Based Assessment of Parkinsonism and Levodopa-Induced Dyskinesia in Persons with Parkinson's Disease. [D] . Li, Michael. 2017

机译：客观的基于视觉的帕金森氏病患者帕金森病和左旋多巴诱发的运动障碍评估。
6. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off [O] . Mikko Kuoppamäki, Mika Leinonen, Werner Poewe -1

机译：恩他卡朋在左旋多巴/卡比多巴与左旋多巴/苄丝肼治疗的帕金森氏病伴衰老患者中的疗效和安全性
7. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off [O] . Mikko Kuoppamäki, Mika Leinonen, Werner Poewe 2015

机译：恩他卡朋在左旋多巴/卡比多巴与左旋多巴/苄丝肼治疗的帕金森氏病伴衰老患者中的疗效和安全性

The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia

摘要

著录项

相似文献

相关主题

期刊订阅